Open Access
| Issue |
BIO Web Conf.
Volume 240, 2026
The 2026 International Conference on Biomedicine, Neuroscience and Biostatistics (ICBNB 2026)
|
|
|---|---|---|
| Article Number | 01011 | |
| Number of page(s) | 4 | |
| Section | Biomedicine, Neuroscience and Biostatistics | |
| DOI | https://doi.org/10.1051/bioconf/202624001011 | |
| Published online | 24 June 2026 | |
- B. L. Musher, S. Vasileiou, B. G. Smaglo, et al. Autologous multiantigen-targeted T cell therapy for pancreatic ductal adenocarcinoma (PDAC): results of a Phase I, three-arm, nonrandomized clinical trial (TACTOPS). Nat. Med. 32, 258–269 (2026). [Google Scholar]
- K. Yang, J. Chu, J. Mei, et al. New strategies for inducing immune “cold” to “hot” conversion in breast cancer. Cancer Res. Prev. Treat. 52, 442–447 (2025). [Google Scholar]
- M. Binnewies, E. W. Roberts, K. Kersten, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541–550 (2018). https://doi.org/10.1038/s41591-018-0014-x [Google Scholar]
- J. Galon, D. Bruni. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197–218 (2019). https://doi.org/10.1038/s41573-018-0007-y [Google Scholar]
- J. Kwon, S. F. Bakhoum. The cytosolic DNA-sensing cGAS-STING pathway in cancer. Cancer Discov. 10, 26–39 (2020). https://doi.org/10.1158/2159-8290.CD-19-0761 [Google Scholar]
- R. Karki, T. D. Kanneganti. Diverging inflammasome signals in tumorigenesis and cancer therapy. Nat. Rev. Cancer. 19, 197–214 (2019). https://doi.org/10.1038/s41568-019-0123-y [Google Scholar]
- S. Yan, X. Sun, K. Wang. From cold to hot tumors: feasibility of applying therapeutic insights to TNBC. Discover Oncology. 16, 1 (2025). https://doi.org/10.1007/s12672-024-01845-6 [Google Scholar]
- Y. Yuan, Y. Tian, X. He, J. Dong, Z. Liu, H. Jing. HSP90 inhibitor-loaded hollow mesoporous nanoparticles for enhanced synergistic mild photothermal/chemotherapy in triple negative breast cancer. Int. J. Biol. Macromol. 303, 143266 (2025). https://doi.org/10.1016/j.ijbiomac.2025.143266 [Google Scholar]
- M. A. Siddiqui, A. Usmani, M. N. Ansari, R. I. M. Almoselhy. Immune-related adverse events in immunotherapy: Challenges in diagnosis, monitoring, and management. Toxicol. Rep. 14, 102036 (2025). https://doi.org/10.1016/j.toxrep.2025.102036 [Google Scholar]
- A. Alhazza, A. Oyegbesan, E. Bousoik, H. Montazeri Aliabadi. Multidrug Resistance: Are We Still Afraid of the Big Bad Wolf. Pharmaceuticals (Basel). 18, 895 (2025). https://doi.org/10.3390/ph18060895 [Google Scholar]
- S. Liu, A. Jiang, F. Tang, M. Duan, B. Li. Drug-induced tolerant persisters in tumor: mechanism, vulnerability and perspective implication for clinical treatment. Mol. Cancer. 24, 150 (2025). https://doi.org/10.1186/s12943-025-02284-x [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.